Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 28, 2015 7:01 AM ET

Healthcare Equipment and Supplies

Company Overview of Affinity Biologicals Inc.

Company Overview

Affinity Biologicals Inc. manufactures research and diagnostic products in the fields of hemostasis, thrombosis, and coagulation. The company specializes in polyclonal antibodies, EIAs, deficient plasmas, enzyme linked immuno-sorbent assay (ELISA) kits, reagents, and control plasmas. It offers coagulation related antibodies, matched-pair antibody sets for ELISA, depleted/deficient plasmas, protease inhibitor deficient plasmas, ELISA kits, coagulation controls and calibration plasmas, and proficiency testing materials. The company also provides medical device manufacturing services; and polyclonal antibody production, contract manufacturing, specialty plasma and control, and protein purificat...

1395 Sandhill Drive

Ancaster, ON L9G 4V5

Canada

Founded in 1987

Phone:

905-304-9896

Fax:

905-304-9897

Key Executives for Affinity Biologicals Inc.

Affinity Biologicals Inc. does not have any Key Executives recorded.

Affinity Biologicals Inc. Key Developments

Affinity Biologicals Introduces an Upgraded Collection of ELISA Kits

Affinity Biologicals has introduced an upgraded collection of ELISA Kits to add ease and efficiency to quantitative and qualitative assessments. With this improved product range, Affinity Biologicals have widened the scope and usage of ELISA Kits. The ELISA Kits offered by Affinity Biologicals allow specific and accurate quantitative and qualitative measurements of hemostasis and thrombosis-related proteins. With these kits, it is possible to assess and measure chemokines, cytokines, immunoglobulins, phosphorylated targets, immunological factors, and growth factors. Biological samples that can be used with these kits include plasma, cell lysates, cell culture supernatants, and serum. Visulize™ Elisa Kits can be used to assess Factor VIII, Factor IX, Factor XI, and TAFI antigens in human plasma samples. These products are VisuLize™ Factor VIII Antigen ELISA Kit, VisuLize™ Factor IX Antigen ELISA Kit, VisuLize™ Factor XI Antigen ELISA Kit and VisuLize™ TAFI Antigen ELISA Kit. All these ELISA Kits ensure accurate, sensitivity to data, and consistent performance. Affinity Biologicals offers FDA-approved VisuLize™ FIX Antigen Kit and VisuLize™ FVIII Antigen Kit.

Similar Private Companies By Industry

Company Name Region
Equi-Tron Manufacturing, Inc. Americas
Spring Loaded Technology Inc. Americas
Vivosonic Inc. Americas
Optique de l'Estrie Americas
Endopisis Medical Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Affinity Biologicals Inc., please visit www.affinitybiologicals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.